These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 15925538)
21. Expression of matrix metalloproteinase 2 and its tissue inhibitor in oral squamous cell carcinoma. Gao ZB; Duan YQ; Zhang L; Chen DW; Ding PT Int J Mol Med; 2005 Oct; 16(4):599-603. PubMed ID: 16142392 [TBL] [Abstract][Full Text] [Related]
22. The relationship of the histologic grade at the deep invasive front and the expression of Ki-67 antigen and p53 protein in oral squamous cell carcinoma. Kurokawa H; Zhang M; Matsumoto S; Yamashita Y; Tanaka T; Tomoyose T; Takano H; Funaki K; Fukuyama H; Takahashi T; Sakoda S J Oral Pathol Med; 2005 Nov; 34(10):602-7. PubMed ID: 16202080 [TBL] [Abstract][Full Text] [Related]
23. Significant relationship of matrix metalloproteinase 9 with nuclear grade and prognostic impact of tissue inhibitor of metalloproteinase 2 for incidental clear cell renal cell carcinoma. Kawata N; Nagane Y; Hirakata H; Ichinose T; Okada Y; Yamaguchi K; Takahashi S Urology; 2007 Jun; 69(6):1049-53. PubMed ID: 17572184 [TBL] [Abstract][Full Text] [Related]
24. High levels of tissue inhibitor of metalloproteinase-2 (TIMP-2) expression are associated with poor outcome in invasive bladder cancer. Grignon DJ; Sakr W; Toth M; Ravery V; Angulo J; Shamsa F; Pontes JE; Crissman JC; Fridman R Cancer Res; 1996 Apr; 56(7):1654-9. PubMed ID: 8603416 [TBL] [Abstract][Full Text] [Related]
25. Histological pattern of mandibular invasion by oral squamous cell carcinoma. Wong RJ; Keel SB; Glynn RJ; Varvares MA Laryngoscope; 2000 Jan; 110(1):65-72. PubMed ID: 10646718 [TBL] [Abstract][Full Text] [Related]
26. [Metalloproteinase (MMP-1, 2 and 11), tissue inhibitor of metalloproteinase-1 (TIMP-1), and p53 expression in nasal-type angiocentric T/NK-cell lymphoma: an immunohistochemical study]. Meneses-García A; Herrera J; Mohar A; García-Cuellar C; Súchil-Bernal L Gac Med Mex; 2005; 141(4):291-6. PubMed ID: 16164124 [TBL] [Abstract][Full Text] [Related]
27. Simultaneous measurement of MMP9 and TIMP1 mRNA in human non small cell lung cancers by multiplex real time RT-PCR. Simi L; Andreani M; Davini F; Janni A; Pazzagli M; Serio M; Orlando C Lung Cancer; 2004 Aug; 45(2):171-9. PubMed ID: 15246188 [TBL] [Abstract][Full Text] [Related]
28. CD44 expression and its relationship with MMP-9, clinicopathological factors and survival in oral squamous cell carcinoma. Kosunen A; Pirinen R; Ropponen K; Pukkila M; Kellokoski J; Virtaniemi J; Sironen R; Juhola M; Kumpulainen E; Johansson R; Nuutinen J; Kosma VM Oral Oncol; 2007 Jan; 43(1):51-9. PubMed ID: 16798062 [TBL] [Abstract][Full Text] [Related]
29. Expression of TIMP-1 and -2 in different growth patterns of adenoid cystic carcinoma. Wang Y; Irié T; Aida T; Tachikawa T Oral Oncol; 2005 Sep; 41(8):821-7. PubMed ID: 15979928 [TBL] [Abstract][Full Text] [Related]
30. Tissue inhibitor of metalloproteinases-1 (TIMP-1) mRNA is elevated in advanced stages of thyroid carcinoma. Shi Y; Parhar RS; Zou M; Hammami MM; Akhtar M; Lum ZP; Farid NR; Al-Sedairy ST; Paterson MC Br J Cancer; 1999 Mar; 79(7-8):1234-9. PubMed ID: 10098765 [TBL] [Abstract][Full Text] [Related]
31. Gelatinase B expression as a prognostic factor in patients with stage II/III rectal carcinoma treated by postoperative adjuvant therapy. Unsal D; Akyurek N; Uner A; Erpolat OP; Han U; Akmansu M; Mentes BB; Dursun A Am J Clin Oncol; 2008 Feb; 31(1):55-63. PubMed ID: 18376229 [TBL] [Abstract][Full Text] [Related]
32. p63 overexpression associates with poor prognosis in head and neck squamous cell carcinoma. Lo Muzio L; Santarelli A; Caltabiano R; Rubini C; Pieramici T; Trevisiol L; Carinci F; Leonardi R; De Lillo A; Lanzafame S; Bufo P; Piattelli A Hum Pathol; 2005 Feb; 36(2):187-94. PubMed ID: 15754296 [TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of p53 expression in oral squamous cell carcinoma without neck node metastases. Carlos de Vicente J; Junquera Gutiérrez LM; Zapatero AH; Fresno Forcelledo MF; Hernández-Vallejo G; López Arranz JS Head Neck; 2004 Jan; 26(1):22-30. PubMed ID: 14724903 [TBL] [Abstract][Full Text] [Related]
35. CD24 expression is a novel prognostic factor in esophageal squamous cell carcinoma. Sano A; Kato H; Sakurai S; Sakai M; Tanaka N; Inose T; Saito K; Sohda M; Nakajima M; Nakajima T; Kuwano H Ann Surg Oncol; 2009 Feb; 16(2):506-14. PubMed ID: 19050962 [TBL] [Abstract][Full Text] [Related]
36. Survivin expression predicts poorer prognosis in patients with areca quid chewing-related oral squamous cell carcinoma in Taiwan. Lin CY; Hung HC; Kuo RC; Chiang CP; Kuo MY Oral Oncol; 2005 Jul; 41(6):645-54. PubMed ID: 15927524 [TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of p53 and matrix metalloproteinase-9 expression in follicular lymphoma. Pennanen H; Kuittinen O; Soini Y; Turpeenniemi-Hujanen T Eur J Haematol; 2008 Oct; 81(4):289-97. PubMed ID: 18616513 [TBL] [Abstract][Full Text] [Related]
38. Prognostic value of MMP-2, -9 and TIMP-1,-2 immunoreactive protein at the invasive front in advanced head and neck squamous cell carcinomas. Ondruschka C; Buhtz P; Motsch C; Freigang B; Schneider-Stock R; Roessner A; Boltze C Pathol Res Pract; 2002; 198(8):509-15. PubMed ID: 12389993 [TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of stromelysin-3 and tissue inhibitor of matrix metalloproteinase-2 in esophageal cancer. Sharma R; Chattopadhyay TK; Mathur M; Ralhan R Oncology; 2004; 67(3-4):300-9. PubMed ID: 15557792 [TBL] [Abstract][Full Text] [Related]
40. Biological markers and prognosis in recurrent oral cancer after salvage surgery. Agra IM; Carvalho AL; Pinto CA; Martins EP; Filho JG; Soares FA; Kowalski LP Arch Otolaryngol Head Neck Surg; 2008 Jul; 134(7):743-9. PubMed ID: 18645125 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]